Public Charity

DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC

DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC is a nonprofit organization categorized as Public Charity based in NEW YORK, NY. Its most recent IRS filing (2024) reports revenue of $6.2M, expenses of $6.3M, total assets of $2.5M. Imperigo tracks 44 reported grant relationships connected to this organization totaling approximately $10.3M.

EIN: 208774179 NEW YORK, NY Research Institutes & Public Policy Analysis NTEE: E05 Latest filing: 2024
Total Revenue$6.2M
Total Expenses$6.3M
Total Assets$2.5M
Grant Records44
Funding Total$10.3M
Filing Years2020–2024

Mission

THE MISSION OF DNDI NORTH AMERICA IS TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GLOBAL OBJECTIVES, IN PARTICULAR TO STRENGHTEN AND EXPAND DNDI'S SCIENTIFIC, POLICY ADVOCACY, FUNDRAISING, AND COMMUNICATIONS EFFORTS IN NORTH AMERICA BY (A) PROVIDING FOCUSED SUPPORT FOR SPECIFIC R&D PROJECTS AND BUSINESS/PARTNER DEVELOPMENT ACTIVITIES IN NORTH AMERICA;(B) ACHIEVING CONCRETE POLICY CHANGES IN NORTH AMERICA TO CREATE A MORE FAVORABLE ENVIRONMENT FOR NEEDS-DRIVEN R&D FOR NEGLECTED DISEASES;(C) MOBILIZING PUBLIC AND PRIVATE FUNDS IN NORTH AMERICA TO SUPPORT DNDI'S MISSION;(D) INCREASING DNDI'S PROFILE AND VISIBILITY IN NORTH AMERICA, THEREBY DRAWING GREATER PUBLIC ATTENTION TO THE NEED FOR NEGLECTED DISEASE R&D.

Where $100 goes at Drugs for Neglected Diseases Initiative North America Inc

How Drugs for Neglected Diseases Initiative North America Inc divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.

$76 Programs the work itself
$10 Management running the organization
$14 Fundraising raising the next dollar

Inside the $76 for programs

$38
Grants to research and development for neglected diseases
50% of program spending
$38
Raising public awareness and advocating for neglected disease r&d:as part of its mission, dndi advocates for enhanced political leadership, increased resources, and an enabling policy environment to stimulate…
About 50% (cost not reported)
Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

BOARD MEMBER Africa Stewart
BOARD MEMBER Bennett Shapiro
CHAIR OF THE BOARD Darin Portnoy
EXECUTIVE DIRECTOR Delali Attipoe
HEAD OF MEDIA AND CONTENT Ilan Moss
TREASURER John Lawrence

Officer compensation and complete director data available with membership.

Top Grant Purposes

Health & Medicine
$9,536,193 21 grants
General Support
$798,293 23 grants

Financial Trends

Year Revenue Expenses Assets
2024 $6.2M $6.3M $2.5M
2023 $4.4M $4.2M $1.8M
2022 $3.9M $3.9M $1.2M
2021 $4.2M $4.0M $1.4M
2020 $3.7M $3.6M $1.5M

Between 2020 and 2024, reported annual revenue grew from $3.7M to $6.2M (+66%), with total assets most recently reported at $2.5M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC

Complete financials, all 44 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time